Erie Indemnity isn't a traditional insurer. It collects fees rather than assuming most underwriting risk, creating one of the most unique business models in financial services. After a rare $1.4 million insider purchase, a 59% decline from all-time highs, and nearly 12 days-to-cover short interest, investors may want another look at this Dividend Aristocrat.

Read entire article

Hamilton Lane (HLNE) may be one of the most attractive alternative asset managers on the market today. Massive insider buying, a growing dividend, a trillion-dollar asset footprint, and expanding private-wealth opportunities combine to create a compelling long-term investment story.

Read entire article

$4M+ in insider buys. 18% revenue growth. Private markets expanding. Hamilton Lane may be a premium compounder trading 47% below its highs.

Read entire article

Insiders are buying, Buffett is in, shorts are nervous—and POOL is 63% off its highs. A deep dive into the maintenance moat behind this backyard empire.

Read entire article

A massive insider buy, a $3B share repurchase program, soaring cash flow, and institutions owning nearly the entire float. Is Roper Technologies signaling deep value—or just tugging on your curiosity rope?

Read entire article

Progress Software's CEO and a director are buying shares, signaling confidence as the company posts strong earnings and raises guidance. With institutional investors owning over 121% of the float, is this under-the-radar compounder set for a rerating?

Read entire article